v3 Template
A
Avextra AG
Pharmaceuticals / Medical Cannabis
Founded
--
Employees
--
Total Funding
$40.0M
Funding Rounds
2
Last Funding
2024-02-07
About Avextra AG
Avextra is a German company focused on the development and production of cannabis-based medicines. Their mission is to create high-quality, evidence-based pharmaceutical products by controlling the entire value chain from cultivation in Portugal to GMP-certified manufacturing in Germany, aiming to improve patient outcomes through research and innovation.
Products & Services
Cannabis-based Medicines:Pharmaceutical products derived from medical cannabis, designed to alleviate symptoms and improve patient quality of life, produced under strict quality standards.
Extracts and Dronabinol:Specialized cannabis extracts and Dronabinol formulations for medical use, focusing on consistency and efficacy.
Avextra THC/CBD Quick Test:A testing kit for pharmacists to ensure accurate identification and dosage of THC/CBD content in products.
Specialties
Cannabis-based Medicines
Research and Development of Evidence-based Therapies
GMP-certified Pharmaceutical Manufacturing
Clinical Studies and Real-World Data Analysis
Herbal Medicine Expertise (over 75 years of experience)
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Follow-on capital raise with Equity instruments and Convertible Loan Notes T: - FT: Follow-on capital raise with Equity instruments and Convertible Loan Notes |
A: 21600000 MR: - FA: above EUR 20 million FAN: 21600000 |
D: 2024-02-07 FD: 2024-02-07 |
4 investors |
| 2 |
RT: Convertible Loan Note T: - FT: Convertible Loan Note |
A: 18360000 MR: - FA: €17 million FAN: 18360000 |
D: 2023-03-15 FD: 2023-03-15 |
3 investors |
Follow-on capital raise with Equity instruments and Convertible Loan Notes
Latest
2024-02-07
$21.6M
4 investors (Pro only)
Convertible Loan Note
2023-03-15
$18.4M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Avextra AG Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- avextra.com
- Industries
- Pharmaceuticals / Medical Cannabis
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro